Lupin gets USFDA nod for generic product
As per IQVIA MAT September 2021 data, Sevelamer Carbonate for Oral Suspension had estimated annual sales of USD 51.7 million in the US.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news